Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Chemed (CHE)

Chemed names Michael Witzeman CFO effective January 1, 2024, succeeding David Williams

Neutral Impact 4 of 5 leadership Written later

Chemed's board appointed Michael D. Witzeman, the company's Vice President and Controller, as Chief Financial Officer effective January 1, 2024. The change follows the retirement of David P. Williams from the CFO role, and Witzeman will also continue as Controller and Vice President.

Key points

  • Michael D. Witzeman appointed CFO by the board on December 18, 2023, effective January 1, 2024
  • Replaces David P. Williams, who is retiring from the CFO role
  • Witzeman joined Chemed in 2005 after Deloitte & Touche LLP and is a licensed CPA
  • Witzeman will keep his Controller and Vice President roles

The filing

CompanyChemed (CHE)
Form8-K, current report
Filed with the SECDec 18, 2023, 4:34 PM ET
Accession number0001562762-23-000442

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 18, 2023.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.